Medicus Pharma Ltd Ordinary Shares MDCX 深 滬
已收盤 10-10 16:00:00 美东时间
2.48
-0.030
-1.20%
華盛通- 最 高2.70
- 今 開2.56
- 成交量 46.16万股
- 最 低 2.4001
- 昨 收 2.51
- 總市值 4418.44万
- 52周最高 8.94
- 市盈率 靜 --
- 換手率 2.59%
- 52周最低 1.7901
- 委 比 74.44%
- 總股本 1781.63万
- 歷史最高 8.94
- 量 比 1.72
- 振 幅 11.95%
- 歷史最低 1.7901
- 每 手 1
- 風險率 1.04%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 潜在涨幅207.38%！GoldMining获HC Wainwright升目标价至3.75美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持GoldMining"买入"评级，目标价从3.25美元升至3.75美元；摩根士丹利：维持Crinetics Pharmaceuticals"超配"评级，目标价从65美元升至77美元
09-30 14:16
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.
09-26 20:10
Medicus Pharma To Present Update On D-MNA And Teverelix Programs On Sept. 29 At Brookline Capital Markets
The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively treat basal cell carcinoma of the skin (BCC) and development of Teverelix, a next generation
09-24 19:43
Lockheed Martin Vectis™: Best in CCA Class Survivability
NATIONAL HARBOR, Md., Sept. 21, 2025 /PRNewswire/ -- Lockheed Martin Skunk Works® (NYSE: LMT) introduces Vectis, a Group 5 survivable and lethal collaborative combat aircraft (CCA) to advanc...
09-21 21:00
Medicus Pharma Appoints Carolyn Bonner as Acting CFO
Medicus Pharma Ltd ( ($MDCX) ) has shared an update. On September 12, 2025, Med...
09-13 05:25
Medicus Pharma Announces SKNJCT-004 Phase 2 Clinical Study, To Non-Invasively Treat BCC Of The Skin, Commences Patient Recruitment In Cleveland Clinic Abu Dhabi
Medicus Pharma Ltd. (NASDAQ:MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics assets, is pleased
09-08 19:33
Medicus Pharma Completes Equity Sales to Yorkville
An update from Medicus Pharma Ltd ( ($MDCX) ) is now available. Medicus Pharma ...
08-23 04:59
Medicus Pharma Ltd. reports Q2 results
Medicus Pharma Ltd. press release (NASDAQ:MDCX): Q2 Net loss for the second quarter was $6.2 million compared to $3.6 million for the same period in 2024. Cash and cash equivalents were $9.7 million a...
08-22 01:51
D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target
D. Boral Capital analyst Jason Kolbert maintains Medicus Pharma (NASDAQ:MDCX) with a Buy and maintains $27 price target.
08-05 19:48
Medicus Pharma and HelixNano Announce Vaccine Collaboration
An announcement from Medicus Pharma Ltd ( ($MDCX) ) is now available. On August...
08-04 19:59
